Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey - Scorecard - MDSpire
Advertisement
Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey
Clinical Scorecard: Global Survey on Variability in Prophylactic Approaches for Infective Endocarditis in Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices
At a Glance
Category
Detail
Condition
Infective Endocarditis (IE)
Key Mechanisms
Device-related infections leading to complications such as lead-associated endocarditis and bacteremia.
Target Population
Pediatric and congenital heart disease patients with cardiac implantable electronic devices (CIEDs).
Care Setting
Clinical practice among members of the Pediatric and Congenital Electrophysiology Society.
Key Highlights
Infective endocarditis is a serious complication in patients with CIEDs.
Current guidelines recommend limited antibiotic prophylaxis based on risk factors.
Pediatric populations may have different risk profiles compared to adults.
Survey aimed to assess contemporary IE prophylaxis practices among clinicians.
Responses reflect combined practice patterns across pediatric and adult congenital heart disease populations.
Guideline-Based Recommendations
Diagnosis
Duke Criteria for IE diagnosis updated in 2020 and 2023.
Management
Single pre-procedural antibiotic dose recommended for CIED implantation.
Monitoring & Follow-up
Clinician-reported practices and experiences with device-related IE.
Risks
Children with CHD face increased risk due to complex anatomy and prior interventions.
Patient & Prescribing Data
Patients with congenital heart disease and cardiac implantable electronic devices.
Antibiotic prophylaxis practices vary based on clinical scenarios and patient risk.
Clinical Best Practices
Consider patient-specific risk factors when determining prophylaxis.
Adhere to updated guidelines for antibiotic prophylaxis in CIED patients.
Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.
